Change in cell mass in japanese nondiabetic Obese individuals

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 9, 2013, Pages 3724-3730

  Kou, Kinsei ^a   Saisho, Yoshifumi ^a   Satoh, Seiji ^a   Yamada, Taketo ^a   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; KI 67 ANTIGEN; SINGLE STRANDED DNA;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOPSY; BODY MASS; CELL DIVISION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPANESE; LEAN BODY WEIGHT; MALE; OBESITY; ORGAN WEIGHT; PANCREAS; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS WEIGHT; PRIORITY JOURNAL; ASIAN; CELL SIZE; JAPAN; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; APOPTOSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CELL DIVISION; CELL SIZE; FEMALE; HUMANS; INSULIN-SECRETING CELLS; JAPAN; MIDDLE AGED; OBESITY; ORGAN SIZE; PANCREAS; RETROSPECTIVE STUDIES;

EID: 84883709891     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1373     Document Type: Article

References (37)

1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. -Cell deficit and increased -cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102-110.
2. Yoon KH, Ko SH, Cho JH, et al. Selective -cell loss and -cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab. 2003;88:2300-2308.
3. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced cell mass and expression of oxidative stressrelated DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia. 2002;45:85-96.
4. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab. 2008;10(suppl 4):32-42.
5. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC. Modestly increased -cell apoptosis but no increased -cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia. 2007;50:2323-2331.
6. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC. Sustained -cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia. 2005;48:2221-2228.
7. Polonsky KS, Given BD, Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988;81:442-448.
8. Saisho Y, Butler AE, Manesso E, Elashoff D, Rizza RA, Butler PC. Cell mass and turnover in humans: effects of obesity and aging. Diabetes Care. 2013;36:111-117.
9. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE. -Cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the US. Diabetes. 2002;51:2170-2178.
10. Oka R, Yagi K, Sakurai M, et al. Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-A ged Japanese. Endocr J. 2012;59:55-64.
11. Heianza Y, Arase Y, Fujihara K, et al. High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8). Diabet Med. 2012;29:1285-1290.
12. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr 2002;8(suppl 11):S732-S737.
13. Naruse I, Keino H, Kawarada Y. Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis. Histochemistry. 1994;101:73-78.
14. Kawarada Y, Miura N, Sugiyama T. Antibody against singlestranded DNA useful for detecting apoptotic cells recognizes hexadeoxynucleotides with various base sequences. J Biochem. 1998; 123:492-498.
15. Watanabe I, Toyoda M, Okuda J, et al. Detection of apoptotic cells in human colorectal cancer by two different in situ methods: antibody against single-stranded DNA and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) methods. Jpn J Cancer Res. 1999;90:188-193.
16. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20:933-942.
17. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women.AnnInternMed. 1995;122:481-486.
18. Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developingcommonchronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581-1586.
19. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-787.
20. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and -cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 1981;68:1456-1467.
21. Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58:773-795.
22. Butler AE, Cao-Minh L, Galasso R, et al. Adaptive changes in pancreatic -cell fractional area and -cell turnover in human pregnancy. Diabetologia. 2010;53:2167-2176.
23. Butler PC, Meier JJ, Butler AE, Bhushan A. The replication of-cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab. 2007;3:758-768.
24. Manesso E, Toffolo GM, Saisho Y, et al. Dynamics of -cell turnover: evidence for -cell turnover and regeneration from sources of -cells other than -cell replication in the HIP rat. Am J Physiol Endocrinol Metab. 2009;297:E323-E330.
25. Bonner-Weir S, Li WC, Ouziel-Yahalom L, Guo L, Weir GC, Sharma A. -Cell growth and regeneration: replication is only part of the story. Diabetes. 2010;59:2340-2348.
26. Rahier J, Goebbels RM, Henquin JC. Cellular composition of the human diabetic pancreas. Diabetologia. 1983;24:366-371.
27. Henquin JC, Rahier J. Pancreatic cell mass in European subjects with type 2 diabetes. Diabetologia. 2011;54:1720-1725.
28. Hsu WC, Boyko EJ, Fujimoto WY, et al. Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications. Diabetes Care. 2012;35:1189-1198.
29. Sone H, Ito H, Ohashi Y, Akanuma Y, Yamada N. Obesity and type 2 diabetes in Japanese patients. Lancet. 2003;361:85.
30. Takahara M, Katakami N, Kaneto H, Noguchi M, Shimomura I. Pancreatic -cell function in lean and obese Japanese with various degrees of glucose tolerance [published online March 16, 2013]. Endocr J. doi:10.1507/endocrj.EJ13- 0046.
31. Saisho Y, Miyakoshi K, Tanaka M, et al. -Cell dysfunction and its clinical significance in gestational diabetes. Endocr J. 2010;57:973-980.
32. Gill TP. Cardiovascular risk in the Asia-Pacific region from a nutrition and metabolic point of view: abdominal obesity. Asia Pac J Clin Nutr. 2001;10:85-89.
33. Kadowaki T, Sekikawa A, Murata K, et al. Japanese men have larger areas of visceral adipose tissue than Caucasianmenin the same levels of waist circumference in a population-based study. Int J Obes (Lond). 2006;30:1163-1165.
34. The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Invest. 2010;1:212-228.
35. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int. 2012;3:8-10.
36. Ogiu N, Nakamura Y, Ijiri I, Hiraiwa K, Ogiu T. A statistical analysis of the internal organ weights of normal Japanese people. Health Phys. 1997;72:368-383.
37. Goda K, Sasaki E, Nagata K, Fukai M, Ohsawa N, Hahafusa T. Pancreatic volume in type 1 and type 2 diabetes mellitus. Acta Diabetol. 2001;38:145-149.